Your browser doesn't support javascript.
loading
Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn's Disease during One-Year Follow-Up.
Bendix, Mia; Dige, Anders; Jørgensen, Søren Peter; Dahlerup, Jens Frederik; Bibby, Bo Martin; Deleuran, Bent; Agnholt, Jørgen.
Afiliação
  • Bendix M; Department of Hepatology and Gastroenterology, Aarhus University Hospital, 8200 Aarhus, Denmark.
  • Dige A; Medical Department, Randers Regional Hospital, 8930 Randers, Denmark.
  • Jørgensen SP; Department of Hepatology and Gastroenterology, Aarhus University Hospital, 8200 Aarhus, Denmark.
  • Dahlerup JF; Department of Hepatology and Gastroenterology, Aarhus University Hospital, 8200 Aarhus, Denmark.
  • Bibby BM; Department of Hepatology and Gastroenterology, Aarhus University Hospital, 8200 Aarhus, Denmark.
  • Deleuran B; Department of Public Health-Department of Biostatistics, Aarhus University, 8000 Aarhus, Denmark.
  • Agnholt J; Department of Rheumatology, Aarhus University Hospital, 8200 Aarhus, Denmark.
Nutrients ; 13(4)2021 Mar 26.
Article em En | MEDLINE | ID: mdl-33810258

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vitamina D / Doença de Crohn / Infliximab Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Revista: Nutrients Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vitamina D / Doença de Crohn / Infliximab Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Revista: Nutrients Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca